塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/08/20 | 6,588 | 6,649 | 6,515 | 6,624 | +130 | +2% | 815,400 |
2024/08/19 | 6,544 | 6,585 | 6,459 | 6,494 | -40 | -0.6% | 589,500 |
2024/08/16 | 6,452 | 6,543 | 6,415 | 6,534 | +112 | +1.7% | 722,900 |
2024/08/15 | 6,358 | 6,444 | 6,341 | 6,422 | +90 | +1.4% | 740,600 |
2024/08/14 | 6,354 | 6,360 | 6,209 | 6,332 | +9 | +0.1% | 996,900 |
2024/08/13 | 6,235 | 6,330 | 6,191 | 6,323 | +48 | +0.8% | 1,639,400 |
2024/08/09 | 6,340 | 6,403 | 6,182 | 6,275 | +35 | +0.6% | 1,341,600 |
2024/08/08 | 6,168 | 6,370 | 6,158 | 6,240 | -28 | -0.4% | 786,600 |
2024/08/07 | 6,050 | 6,491 | 6,041 | 6,268 | +109 | +1.8% | 1,550,100 |
2024/08/06 | 6,140 | 6,304 | 6,014 | 6,159 | +312 | +5.3% | 1,850,800 |
2024/08/05 | 6,250 | 6,338 | 5,834 | 5,847 | -523 | -8.2% | 2,395,700 |
2024/08/02 | 6,223 | 6,418 | 6,215 | 6,370 | -53 | -0.8% | 1,403,700 |
2024/08/01 | 6,549 | 6,570 | 6,334 | 6,423 | -174 | -2.6% | 1,126,900 |
2024/07/31 | 6,585 | 6,629 | 6,495 | 6,597 | +30 | +0.5% | 1,603,400 |
2024/07/30 | 6,493 | 6,569 | 6,403 | 6,567 | -239 | -3.5% | 2,360,800 |
2024/07/29 | 6,820 | 6,887 | 6,782 | 6,806 | +59 | +0.9% | 885,100 |
2024/07/26 | 6,737 | 6,809 | 6,728 | 6,747 | +42 | +0.6% | 942,700 |
2024/07/25 | 6,745 | 6,796 | 6,672 | 6,705 | -28 | -0.4% | 1,062,100 |
2024/07/24 | 6,822 | 6,857 | 6,721 | 6,733 | -159 | -2.3% | 896,500 |
2024/07/23 | 6,850 | 6,917 | 6,817 | 6,892 | +122 | +1.8% | 1,453,900 |
2024/07/22 | 6,750 | 6,772 | 6,678 | 6,770 | +14 | +0.2% | 897,100 |
2024/07/19 | 6,620 | 6,761 | 6,614 | 6,756 | +39 | +0.6% | 940,500 |
2024/07/18 | 6,637 | 6,780 | 6,625 | 6,717 | +92 | +1.4% | 1,035,800 |
2024/07/17 | 6,584 | 6,649 | 6,541 | 6,625 | +25 | +0.4% | 896,000 |
2024/07/16 | 6,642 | 6,671 | 6,583 | 6,600 | -43 | -0.6% | 955,800 |
2024/07/12 | 6,635 | 6,729 | 6,604 | 6,643 | -47 | -0.7% | 1,753,900 |
2024/07/11 | 6,548 | 6,718 | 6,540 | 6,690 | +228 | +3.5% | 1,957,800 |
2024/07/10 | 6,401 | 6,489 | 6,363 | 6,462 | +86 | +1.3% | 1,426,900 |
2024/07/09 | 6,283 | 6,379 | 6,262 | 6,376 | +79 | +1.3% | 1,558,700 |
2024/07/08 | 6,221 | 6,299 | 6,215 | 6,297 | +69 | +1.1% | 1,192,700 |
2024/07/05 | 6,220 | 6,262 | 6,201 | 6,228 | +32 | +0.5% | 821,700 |
2024/07/04 | 6,197 | 6,225 | 6,184 | 6,196 | +2 | ±0% | 702,700 |
2024/07/03 | 6,190 | 6,226 | 6,160 | 6,194 | -34 | -0.5% | 1,159,200 |
2024/07/02 | 6,245 | 6,259 | 6,188 | 6,228 | -4 | -0.1% | 1,223,300 |
2024/07/01 | 6,278 | 6,327 | 6,203 | 6,232 | -45 | -0.7% | 1,011,900 |
2024/06/28 | 6,278 | 6,290 | 6,239 | 6,277 | +21 | +0.3% | 1,560,100 |
2024/06/27 | 6,220 | 6,258 | 6,189 | 6,256 | +5 | +0.1% | 1,065,000 |
2024/06/26 | 6,270 | 6,293 | 6,225 | 6,251 | +27 | +0.4% | 1,614,500 |
2024/06/25 | 6,149 | 6,224 | 6,117 | 6,224 | +100 | +1.6% | 1,514,000 |
2024/06/24 | 6,012 | 6,128 | 5,980 | 6,124 | +116 | +1.9% | 1,472,100 |
2024/06/21 | 6,066 | 6,085 | 5,998 | 6,008 | -118 | -1.9% | 3,205,600 |
2024/06/20 | 6,078 | 6,146 | 6,065 | 6,126 | +58 | +1% | 1,065,200 |
2024/06/19 | 6,080 | 6,104 | 6,051 | 6,068 | -29 | -0.5% | 1,071,300 |
2024/06/18 | 6,154 | 6,169 | 6,072 | 6,097 | -50 | -0.8% | 1,407,800 |
2024/06/17 | 6,120 | 6,148 | 6,044 | 6,147 | +62 | +1% | 1,423,300 |
2024/06/14 | 6,000 | 6,117 | 6,000 | 6,085 | -9 | -0.1% | 2,187,100 |
2024/06/13 | 6,112 | 6,139 | 6,010 | 6,094 | -3 | ±0% | 1,722,200 |
2024/06/12 | 6,059 | 6,118 | 5,985 | 6,097 | -3 | ±0% | 2,892,300 |
2024/06/11 | 6,201 | 6,228 | 6,100 | 6,100 | -186 | -3% | 3,948,000 |
2024/06/10 | 6,315 | 6,319 | 6,245 | 6,286 | -15 | -0.2% | 3,027,200 |
151~
200
件表示中 / 3672件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 226,700円 | +5.7% | +3.9% | 2.53% | 11.28倍 | 1.49倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 760,000円 | +2.2% | +10.2% | 1.58% | 14.64倍 | 1.47倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 137,500円 | +18.5% | -96.0% | 5.38% | 175.84倍 | 1.61倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 390,500円 | +1.7% | -2.9% | 4.10% | 25.62倍 | 1.34倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 211,900円 | -3.5% | -11.3% | 2.83% | 19.46倍 | 1.30倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム